Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.45 |
| ▸ | ITGAV | P06756 | 19/20 | 0.45 |
| ▸ | ITGB6 | P18564 | 14/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.44 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.44 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.44 |
| ▸ | ITGB8 | P26012 | 1/20 | 0.44 |
| ▸ | ITGA8 | P53708 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6776927 | 0.88 | ITGB3 (0.47) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL7843541 | 0.85 | MEN1 (0.40) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL6776905 | 0.85 | ITGB3 (0.53) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL6782859 | 0.82 | ITGB3 (0.57) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL6777241 | 0.81 | ITGB3 (0.58) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL7843535 | 0.81 | RAB9A (0.42) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL30625724 | 0.81 | ITGB3 (0.51) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL6778166 | 0.81 | ITGB3 (0.51) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL7823055 | 0.80 | ITGB3 (0.43) | ITGB3ITGAVITGB6ITGB1ITGA5 | |
| SCHEMBL6777144 | 0.79 | ITGB3 (0.59) | ITGB3ITGAVITGB6ITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0850221-B1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | SEARLE & CO (US) | 2001-07-18 | — | — | EP | claimed |